DESIGN AND FABRICATION OF MEDICATED CHOCOLATE FORMULATION BY CHOCOLATE DRUG DELIVERY SYSTEM
Objective: The objective of this study is to design and fabricate Chlorpheniramine Maleate chocolate formulation by chocolate drug delivery system. Chlorpheniramine Maleate binds to histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of negative symptoms brought on by histamine.
Methods: Chocolate is a range of products derived from cocoa (cacao), mixed with fat (i.e., cocoa butter) and finely powdered sugar to produce a solid confectionery. The medicated chocolate formulation is widely used for pediatric administration and increases patient compliance. Chlorpheniramine Maleate chocolate formulation is prepared to improve patient compliance. Chocolates were formulated (F1-F3) with a total fat of 25-35 % (w/w) from cocoa liquor and cocoa butter with more than 34% total cocoa, composition as specified for dark chocolate, lecithin, sweetening agents.
Results: The prepared chocolate formulations were evaluated for general appearance, drug content, In vitro drug release and DSC and FTIR, moisture content and blooming tests. F1 formulation releases complete drug within 60 min.
Conclusion: The results indicate that the formulation has no drug excipient interactions and there was no degradation in drug, it is stable during chocolate formulation preparation.
2. Sastry SV, Nyshdham JR. Review of formulation used in oral cavity. Pharm Sci Technol Today 2000;3:138-45.
3. Batheja P. Basic biopharmaceutics of buccal and sublingual absorption, enhancement in drug delivery. London, New York. Touitou E, Barry BW. editors. CRC Press: Taylor and Francis Group; 2006. p. 189.
4. Nidhi Patel, Saleha Diwan, Kajal Shukla, Priyanka Tomar, Hitesh Jain, Prasanna Pradhan, et al. Chocolate drug delivery system: a review. Indo Am J Pharm Sci 2015;2:1077-81.
5. Sharma M, Jain DK. Chocolate formulation as drug delivery system for pediatrics. Indonesian J Pharm 2012;23:216-24.
6. Lang KW. Delivery of active agents using a chocolate vehicle. US Patent 0269558; 2007.
7. Afoakwa EO, Paterson A, Fowler M. Chocolate science and technology. Wiley-Blackwell Publication 2008;226:1259.
8. Davide G, Cristina L, Stefano N, Giovambattista D, Claudio F. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005;81:611-4.
9. James F, Gerd P, Albert K. Effect of chocolate on acne vulgaris. J Am Med Assoc 1969;210:2071-4.
10. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug deliveryâ€“a review. Pharm Sci Technol Today 2000;3:138-44.
11. Knight Ian. Chocolate and Cocoa: Health and Nutrition. Blackwell Publication; 1999.
12. Rodgers C. The role of aversive bittering agents in the prevention of pediatric poisonings. Pediatrics 1994;93:68-9.
13. Chirag Vasani, Ketan Shah. Preparation and evaluation of chocolate drug delivery system of albendazole. Res J Pharm Tech 2016;9:1994-8.
14. Viswanath V, Narasimharao B, Purushothaman M, Sireesha S. Formulation and evaluation of fexofenadine hydrochloride and paracetamol chocolate for pediatrics. World J Pharm Res 2015;4:842-58.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.